• BioStrand secures second VLAIO research grant

    Thursday January 13th 2022

  • New start-up Trince raises EUR 4 million for innovative technology to produce personalized cancer therapies safer, cheaper, and faster

    Monday December 6th 2021

  • Celyad Oncology announces $32.5 million private placement with Fortress Investment Group

    Monday December 6th 2021

  • OXURION NV secures EUR 10 million convertible bond financing from Kreos Capital and Pontifax Ventures

    Monday November 22nd 2021

  • Thirona closes financing round with HERAN Partners and Borski Fund

    Thursday October 28th 2021

  • Biotalys awarded multi-year grant to develop new biological solutions for cowpea and other legumes

    Wednesday October 20th 2021

  • Rejuvenate Biomed raises a EUR 15.7 million Series B to accelerate clinical development of its sarcopenia treatment for healthy aging

    Tuesday October 12th 2021

  • S-Biomedic announces completion of prestigious financing with European Innovation Council Fund

    Friday October 1st 2021

  • Your news here?

  • Newton Biocapital invests in PRISM BioLab to support development of a unique peptide mimetic technology platform to discover new drugs for intractable diseases

    Thursday September 9th 2021

  • Novalis Biotech Acceleration invests in San Francisco-based Modality.AI - technology that ‘self-drives’ neurological and psychiatric assessments

    Friday September 3rd 2021

  • Ardena’s success leads to major €35 million investment for expansion in Belgium, Sweden and The Netherlands

    Thursday July 15th 2021

Strategic Partners